Researchers at Cleveland Clinic and Case Western Reserve University have developed a new method that could potentially help provide better access to lung transplant for transplant candidates who are hard to match because of their blood type or height.
SciRhom GmbH, a biotech startup co-founded by Hospital for Special Surgery (HSS), recently secured a 63 million euro (US$70 million) Series A financing round to support the clinical development of its novel drug candidate, SR-878. The round was co-led by Andera Partners, Kurma Partners, Hadean Ventures, MIG Capital, and Wellington Partners, with participation from new investor Bayern Kapital and existing investors. This news follows the company’s recently received approval from Austrian regulatory authorities (BASG/AGES) required to commence its first-in-human Phase I clinical trial in Europe this fall.
Accure Acne, Inc.™ (www.accureacne.com), a pioneer in the development of innovative solutions for the treatment of acne, announced today that it has received a new FDA Clearance K242035 for the long-term treatment of mild to severe inflammatory acne vulgaris.
The interlinked global crises of biodiversity loss, climate change, and threats to human and wildlife health are continuing to accelerate, posing existential threats to biodiversity and human well-being, and undermining efforts to implement the Global Biodiversity Framework. Maintaining and improving ecological integrity–structure, composition, and function–is central to addressing all three of these crises, and its importance is reflected within the GBF and the UNFCCC Paris Agreement.
The Wayne State University College of Education was awarded $600,000 from the William T. Grant Foundation to study the impact of mixed-income neighborhood initiatives on educational inequality for Black low-income youth. “How do Mixed-Income Neighborhood Initiatives Reduce Educational Inequality for Low-Income Black Youth?” will be conducted through the Detroit Partnership for Education Equity & Research (Detroit PEER), a college research center that conducts collaborative, community-centered and equity-focused studies to improve the Detroit educational ecosystem.
JMIR Publications is proud to announce that Gunther Eysenbach, founder, CEO and executive editor, has once again been named the #1 most cited researcher in the subfield of medical informatics by Stanford/Elsevier’s Top 2% Scientists rankings.
For decades, Sandia National Laboratories’ National Solar Thermal Test Facility has harnessed the power of the sun to expose aerospace materials to intense heat, replicating the harsh conditions of faster-than-sound flight and atmospheric reentry to ensure the materials’ ability to protect the rest of the vehicle. The most recent of these tests is in support of two exciting NASA missions.
Microcombs, miniature devices generating precise light colors, are becoming more efficient. By harnessing powerful light interactions and ultra-low-loss materials, scientists have boosted microcomb efficiency from a few per cent to over 50 per cent. This paves the way for smaller, more powerful devices with applications in various fields beyond research labs. However, there are still challenges to address.
Microcombs, essential for precise time and frequency measurements, are transforming various fields. These compact devices enable high-speed communication, high-resolution metrology and accurate atomic clocks while bridging fundamental science with practical applications. Recent advancements offer new possibilities in classical and quantum information processing.
Photon-pair sources are essential resources for quantum technologies, and their chip-scale integration is crucial for realizing compact and scalable quantum systems. Recently, researchers from A*STAR and NUS in Singapore developed a nanophotonic waveguide that can efficiently generate photon pairs on-chip.
As cannabidiol products — commonly known as CBD — become more readily available, West Virginia University researchers are working to gain a broader understanding of how the substance influences driving performance and whether the effects differ between men and women.
In a new study led by Johns Hopkins Medicine, the drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone (breast cancer bone metastasis). RK-33 was previously shown to help treat other types of cancer and viral illnesses.
Seizure action plans often are aimed at a subset of people with epilepsy, particularly children. Dr. Lucretia Long discusses how these plans can be used to engage and educate people with epilepsy, their families, and the larger community.